Parametric Portfolio Associates’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Parametric Portfolio Associates’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$6K	Sell	45 -6	-12%	-$876	﹤0.01%	3668
2021 Q4	$9K	Sell	51 -21	-29%	-$7.83K	﹤0.01%	3625
2021 Q3	$36K	Sell	72 -2	-3%	-$927	﹤0.01%	3588
2021 Q2	$37K	Buy	+74	New	+$39.7K	﹤0.01%	3548
2015 Q2	–	Sell	-214	Closed	-$484K	–	4015
2015 Q1	$484K	Sell	214 -1	-0.5%	-$1.71K	﹤0.01%	3283
2014 Q4	$222K	Sell	215 -96	-31%	-$103K	﹤0.01%	3729
2014 Q3	$329K	Buy	311 +182	+141%	+$306K	﹤0.01%	3419
2014 Q2	$323K	Buy	129 +41	+47%	+$83.7K	﹤0.01%	3477
2014 Q1	$168K	Hold	88	–	–	﹤0.01%	3667
2013 Q4	$188K	Sell	88 -11	-11%	-$26K	﹤0.01%	3640
2013 Q3	$222K	Sell	99 -2	-2%	-$3.87K	﹤0.01%	3565
2013 Q2	$175K	Buy	+101	New	+$160K	﹤0.01%	3500

Other funds holding AMPE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

WWM

Western Wealth Management Golden, Colorado $3.06B AUM 26.31% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

Parametric Portfolio Associates's AMPE Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Ampio Pharmaceuticals Inc. (AMPE) stake by 12% in Q1 2022, selling an estimated $876 and leaving 45 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #3668.

Parametric Portfolio Associates first reported a position in AMPE in Q2 2013 and has held it in 12 quarters since. The position peaked at $484K in Q1 2015. 128 funds tracked by Wall St. Rank hold AMPE as of Q1 2022.

Parametric Portfolio Associates held 45 shares of Ampio Pharmaceuticals Inc. worth $6K as of Q1 2022.
Parametric Portfolio Associates sold 6 Ampio Pharmaceuticals Inc. shares in Q1 2022, an estimated $876.
Ampio Pharmaceuticals Inc. made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3668 holding.
Parametric Portfolio Associates first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and has held it in 12 quarters since.
Parametric Portfolio Associates's Ampio Pharmaceuticals Inc. position peaked at $484K in Q1 2015.
128 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.